SCLP — Scancell Holdings Income Statement
0.000.00%
Last trade - 00:00
- £153.38m
- £160.12m
- £5.27m
2019 April 30th | 2020 April 30th | 2021 April 30th | R2022 April 30th | 2023 April 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 0 | 5.27 |
Cost of Revenue | |||||
Gross Profit | — | — | — | — | 4.75 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 6.73 | 6.78 | 8.83 | 20.5 | 17.2 |
Operating Profit | -6.73 | -6.78 | -8.83 | -20.5 | -11.9 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -6.71 | -6.77 | -16.8 | -6.27 | -14.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | -5.63 | -5.51 | -15.5 | -4.57 | -11.9 |
Net Income Before Extraordinary Items | |||||
Net Income | -5.63 | -5.51 | -15.5 | -4.57 | -11.9 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -5.63 | -5.51 | -15.5 | -4.57 | -11.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.014 | -0.012 | -0.024 | -0.001 | -0.015 |